Michael J. Moss,
MD
Languages Spoken: English
Dr. Moss is triple board-certified in medical toxicology, addiction medicine, and emergency medicine.
He serves as the medical director of the Utah Poison Control Center.
He provides inpatient consultation on toxicology patients at the University of Utah and Primary Children's Hospital and works in the University of Utah Hospital Emergency Department.
He also provides inpatient consultation on addiction medicine (opioid use disorder, medication assisted treatment, alcohol withdrawal, etc.) at the University Hospital.
For toxicology consultation please contact the Utah Poison Control Center at 1-800-222-1222.
Clinical Locations
Emergency Medicine
801-585-9397
Specialties
Board Certification and Academic Information
| Academic Departments | Emergency Medicine
-
Assistant Professor (Clinical) Pharmacotherapy - Adjunct Assistant Professor Psychiatry - Adjunct Assistant Professor |
| Academic Divisions | Adult Psychiatry |
| Board Certification | American Board of Emergency Medicine (Emergency Medicine) American Board of Emergency Medicine (Sub: Medical Toxicology) American Board of Preventive Medicine (Addiction Medicine) |
Dr. Moss is triple board-certified in medical toxicology, addiction medicine, and emergency medicine.
He serves as the medical director of the Utah Poison Control Center.
He provides inpatient consultation on toxicology patients at the University of Utah and Primary Children's Hospital and works in the University of Utah Hospital Emergency Department.
He also provides inpatient consultation on addiction medicine (opioid use disorder, medication assisted treatment, alcohol withdrawal, etc.) at the University Hospital.
For toxicology consultation please contact the Utah Poison Control Center at 1-800-222-1222.
Academic Locations
L.S. Skaggs Pharmacy Institute
Board Certification and Academic Information
| Academic Departments | Emergency Medicine
-
Assistant Professor (Clinical) Pharmacotherapy - Adjunct Assistant Professor Psychiatry - Adjunct Assistant Professor |
| Academic Divisions | Adult Psychiatry |
| Board Certification | American Board of Emergency Medicine (Emergency Medicine) American Board of Emergency Medicine (Sub: Medical Toxicology) American Board of Preventive Medicine (Addiction Medicine) |
Education History
| Fellowship | Oregon Health & Science University Medical Toxicology Fellow, 2018 |
| Chief Resident | Virginia Commonwealth University School of Medicine Emergency Medicine Chief Resident, 2016 |
| Residency | Virginia Commonwealth University School of Medicine Emergency Medicine Resident, 2015 |
| Professional Medical | Ohio State University College of Medicine Medicine M.D., 2013 |
| Undergraduate | Brigham Young University Physiology and Developmental Biology B.S., 2007 |
Selected Publications - Journal Articles
Journal Article
- Moss MJ, Bushlin I, Kazmierczak S, Koop D, Hendrickson RG, Zuckerman KE, Grigsby TM (2021). Cannabis use and measurement of cannabinoids in plasma and breast milk of breastfeeding mothers. Pediatr Res.
- Giannouchos TV, Biskupiak J, Moss MJ, Brixner D, Andreyeva E, Ukert B (2020). Trends in outpatient emergency department visits during the COVID-19 pandemic at a large, urban, academic hospital system. Am J Emerg Med, 40, 20-26.
- Grigsby TM, Hoffmann LM, Moss MJ (2020). Marijuana Use and Potential Implications of Marijuana Legalization. Pediatr Rev, 41(2), 61-72.
- Moss MJ, Hendrickson RG, Toxicology Investigators Consortium ToxIC (2019). Serotonin Toxicity: Associated Agents and Clinical Characteristics. J Clin Psychopharmacol, 39(6), 628-633.
- Amirshahi MM, Moss MJ, Smith SW, Nelson LS, Stolbach AI (4/4/2019). ACMT Position Statement: Addressing Pediatric Cannabis Exposure. J Med Toxicol, 15(3), 212-214.
- Moss MJ, Fisher JA, Kenny TA, Palmer AC, Thompson JA, Wolfer H, Hendrickson RG (2019). Salicylate toxicity after undetectable serum salicylate concentration: a retrospective cohort study. Clin Toxicol (Phila), 57(2), 137-140.
- Moss MJ, Hendrickson RG (2019). Toxicity of muscimol and ibotenic acid containing mushrooms reported to a regional poison control center from 2002-2016. Clin Toxicol (Phila), 57(2), 99-103.
- Moss MJ, Warrick BJ, Nelson LS, McKay CA, Dub PA, Gosselin S, Palmer RB, Stolbach AI (2018). ACMT and AACT position statement: preventing occupational fentanyl and fentanyl analog exposure to emergency responders. Clin Toxicol (Phila), 56(4), 297-300.
- Moss MJ, Maskell KF, Hieger MA, Wills BK, Cumpston KL (2017). An algorithm for identifying mothball composition. Clin Toxicol (Phila), 55(8), 919-921.
- Hieger MA, Maskell KF, Moss MJ, Powell SW, Cumpston KL (2017). Dofetilide in Overdose: A Case Series from Poison Center Data. Cardiovasc Toxicol, 17(3), 368-371.
Case Report
- Rodriguez SA, Moss MJ (2020). Pediatric brexpiprazole toxicity. Clin Toxicol (Phila), 58(12), 1354-1355.
- Wolf CE, Poklis JL, Cumpston K, Moss M, Poklis A (2017). Acute dilated cardiomyopathy and myocardial injury after combined 4-fluoroamphetamine and modafinil ingestion. Drug Test Anal, 9(4), 657-659.
Letter
Video/Film/CD/Web/Podcast
- Teemant K, Crouch BI, Bennet H, Rhien T, Moss M (2019). Naloxone 101 Training. [Web]. Utah Department of Health.